RenovoRx Inc., a San Jose, CA-based medical device company that is developing novel catheter technologies enabling delivery of fluids to the peripheral vessels, closed a $1.15m Series B financing round.
The round was led by Golden Seeds, with participation from The Angels’ Forum, Halo Fund, Sand Hill Angels, and new investors Astia Angels and Amidzad Partners.
The company intends to use the funds to support important milestones and to meet clinical need for its system in 2014.
Founded in 2009 and led by Marta Gaia Zanchi, CEO, Kamran Najmabadi, COO/CTO, and Ramtin Agah, CMO, RenovoRx develops solutions for direct and localized delivery of fluids, including radiopaque material and therapeutic agents, to selected sites in the peripheral vascular system.
FinSMEs
28/01/2014